Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock: What's Going On? [Yahoo! Finance]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: Yahoo! Finance
As per data from Benzinga Pro, BuzzFeed shares are trading on a strong session volume of 4.84 million compared to an average 100-day volume of 938.86k. Related: BuzzFeed Shares More Than Double Following $108.6M Complex Sale, Plans To Layoff 16% Staff According to the SEC filing, Ramaswamy “will engage in a dialogue with (BuzzFeed's) Board of Directors and/or management about numerous operational and strategic opportunities to maximize shareholder value, including a shift in the company's strategy.” A multi-millionaire who dropped out of the U.S. presidential race in January this year, Ramaswamy founded the biotech firm Roivant Sciences Ltd (NASDAQ: ROIV Once valued at $1.7 billion, Buzzfeed has experienced a steep decline in its stock value, prompting the company to divest its news operation and seek buyers for subsidiaries like Complex Networks Recently, BuzzFeed entered into a multi-year license and strategic partnership with Independent Digital News and Media. The agr
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- Dermavant Announces Approval of Tapinarof in both Psoriasis and Atopic Dermatitis in Japan [Yahoo! Finance]Yahoo! Finance
- MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update [Yahoo! Finance]Yahoo! Finance
ROIV
Earnings
- 5/30/24 - Beat
ROIV
Sec Filings
- 6/24/24 - Form 4
- 6/24/24 - Form 4
- 6/24/24 - Form 4
- ROIV's page on the SEC website